PAPER
Synthesis of Weinreb Amides Directly from Carboxylic Acids
327
IR (neat): 3402, 2963, 1719, 1647, 1560, 1542, 1422, 1389, 1179,
999, 783 cm–1.
MS (70 eV): m/z (%) = 271 (0.3), 244 (12), 183 (75), 109 (21), 95
(32), 85 (29), 71 (38), 61 (100), 57 (87).
1H NMR (400 MHz, CDCl3): δ = 4.22 (s, 2 H), 3.72 (s, 3 H), 3.20
(s, 3 H).
13C NMR (100 MHz, CDCl3): δ = 167.5, 61.6, 40.7, 32.5.
N-Methoxy-N-methylpalmitamide (5p)50
White solid; yield: 257 mg (95%); mp 28–29 °C.
IR (neat): 3439, 2924, 2853, 1671, 1462, 1382, 1002, 913 cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.68 (s, 3 H), 3.18 (s, 3 H), 2.41
(t, J = 7.6 Hz, 2 H), 1.64–1.61 (m, 2 H), 1.30–1.25 (m, 24 H), 0.88
(t, J = 6.8 Hz, 3 H).
MS (70 eV): m/z (%) = 139 (2), 137 (5), 107 (9), 79 (11), 77 (39),
61 (100), 58(19), 49 (23), 46 (25).
3-Chloro-N-methoxy-N-methylpropanamide (5k)38,39
Colorless oil; yield: 285 mg (94%).
13C NMR (100 MHz, CDCl3): δ = 175.1, 61.4, 32.2, 29.9, 29.8, 29.7,
29.7, 29.6, 24.9, 22.9, 14.4.
IR (neat): 3312, 2971, 2940, 2823, 1665, 1427, 1389, 1319, 1298,
1180, 1105, 992 cm–1.
MS (70 eV): m/z (%) = 300 (3), 240 (15), 239 (93), 95 (25), 85 (36),
71 (51), 61 (100), 57 (70).
1H NMR (400 MHz, CDCl3): δ = 3.84–3.72 (m, 2 H), 3.17 (s, 3 H),
3.21 (s, 3 H), 2.94–2.91 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 170.7, 61.3, 39.2, 34.9, 32.0.
(S)-N-Methoxy-N-methyl-2-(4-methylphenylsulfonamido)-3-
phenylpropanamide (7a)51
20
White solid; yield: 673 mg (93%); mp 91–92 °C; [α]D +13.1 (c
MS (70 eV): m/z (%) = 151 (16), 153 (5), 152 (2), 116 (6), 91 (33),
93 (10), 86 (7), 61 (100).
0.36, MeOH).
IR (neat): 3029, 2931, 2869, 1658, 1601, 1449, 1386, 1332, 1159,
1088, 1026, 987 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.59–7.58 (m, 2 H), 7.24–7.18 (m,
5 H), 7.10–7.08 (m, 2 H), 5.39 (d, J = 9.2 Hz, 1 H), 4.56–4.50 (m, 1
H), 3.43 (s, 3 H), 2.96 (s, 3 H), 2.86–2.81 (m, 2 H), 2.38 (s, 3 H).
5-Bromo-N-methoxy-N-methylpentanamide (5l)9
Colorless oil; yield: 417 mg (93%).
IR (neat): 3487, 2939, 1733, 1660, 1447, 1418, 1387, 1240, 994
cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.69 (s, 3 H), 3.43 (t, J = 6.8 Hz,
2 H), 3.19 (s, 3 H), 2.47 (t, J = 7.2 Hz, 2 H), 1.96–1.75 (m, 4 H).
13C NMR (100 MHz, CDCl3): δ = 175.6, 143.3, 136.9, 135.8, 129.5,
129.4, 128.4, 127.2, 126.9, 61.2, 54.0, 39.7, 32.0, 21.5.
13C NMR (100 MHz, CDCl3): δ = 173.9, 61.2, 33.3, 32.2, 32.1, 30.8,
23.2.
MS (70 eV): m/z (%) = 362 (0.58), 347 (0.24), 316 (12), 274 (88),
271 (68), 155 (96), 131 (12), 119 (12), 91 (100), 71 (14).
MS (70 eV): m/z (%) = 225 (4), 224 (5), 165 (43), 144 (11), 137
(26), 135 (29), 61 (100), 55 (93).
(S)-N-Methoxy-N-methyl-2-(4-methylphenylsulfonamido)-2-
phenylacetamide (7b)52
White solid; yield: 669 mg (89%); mp 138–140 °C; [α]D20 +88.43 (c
0.32, MeOH).
6-Bromo-N-methoxy-N-methylhexanamide (5m)48
Colorless oil; yield: 452 mg (95%).
IR (neat): 3283, 3063, 2926, 2859, 1659, 1600, 1449, 1383, 1331,
1160, 1090, 991 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.62–7.60 (m, 2 H), 7.26–7.17 (m,
7 H), 6.03 (d, J = 6.4 Hz, 1 H), 5.43 (d, J = 7.6 Hz, 1 H), 3.28 (s, 3
H), 2.99 (s, 3 H), 2.37 (s, 3 H).
13C NMR (100 MHz, CDCl3): δ = 169.9, 143.2, 137.2, 136.3, 129.3,
128.7, 128.3, 127.7, 127.1, 61.0, 26.9, 32.3, 21.5.
IR (neat): 3450, 2932, 1731, 1656, 1458, 1386, 1176, 996 cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.69 (s, 3 H), 3.42 (t, J = 6.8 Hz,
2 H), 3.18 (s, 3 H), 2.44 (t, J = 7.2 Hz, 2 H), 1.94–1.85 (m, 2 H),
1.72–1.60 (m, 2 H), 1.54–1.45 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 174.3, 61.2, 33.7, 32.5, 32.1, 31.6,
27.9, 23.7.
MS (70 eV): m/z (%) = 238 (1), 179 (30), 177 (32), 103 (12), 74
(22), 69 (100), 61 (68).
MS (70 eV): m/z (%) = 260 (100), 155 (56), 91 (51), 77 (4), 65 (6).
(S)-N-Methoxy-N-methyl-2-(4-methylphenylsulfonami-
do)propanamide (7c)52
6-Iodo-N-methoxy-N-methylhexanamide (5n)
Colorless oil; yield: 536 mg (94%).
White solid; yield: 555 mg (97%); mp 71–72 °C; [α]D20 +35 (c 2.1
in CH2Cl2).
IR (neat): 3430, 2932, 1656, 1458, 1383, 1170, 996 cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.71 (s, 3 H), 3.22 (t, J = 6.8 Hz,
2 H), 3.18 (s, 3 H), 2.45 (d, J = 6.0 Hz, 2 H), 1.90–1.82 (m, 2 H),
1.69–1.62 (m, 2 H), 1.49–1.45 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 174.1, 61.1, 33.1, 31.9, 31.4, 30.1,
23.3, 6.8.
IR (neat): 3248, 3063, 2980, 2937, 1659, 1600, 1447, 1387, 1333,
1159, 1091, 987 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.72 (d, J = 8.0 Hz, 2 H), 7.28 (d,
J = 7.6 Hz, 2 H), 5.57 (d, J = 8.8 Hz, 1 H), 4.34 (t, J = 7.6 Hz, 1 H),
3.56 (s, 3 H), 2.99 (s, 3 H), 2.41 (s, 3 H), 1.31–1.26 (m, 3 H).
HRMS (ESI): m/z [M + H]+ calcd for C8H17INO2: 286.0298; found:
286.0302.
13C NMR (100 MHz, CDCl3): δ = 172.3, 143.4, 136.9, 129.5, 127.3,
61.4, 48.8, 32.1, 21.5, 19.9.
N-Methoxy-N-methyldodecanamide (5o)49
Colorless oil; yield: 457 mg (94%).
MS (70 eV): m/z (%) = 286 (0.015), 259 (3), 226 (2), 198 (100), 155
(87), 91 (65), 65 (10).
IR (neat): 3446, 2925, 2854, 1671, 1463, 1413, 1382, 1176, 999
cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.67 (s, 3 H), 3.17 (s, 3 H), 2.41
(t, J = 6.8 Hz, 2 H), 1.70–1.59 (m, 2 H), 1.30–1.27 (m, 16 H), 0.87
(t, J = 6.7 Hz, 3 H).
13C NMR (100 MHz, CDCl3): δ = 174.8, 61.2, 32.1, 31.9, 29.7, 29.6,
29.5, 29.4, 29.4, 29.3 24.6, 22.6, 14.1.
(S)-N-Methoxy-N-methyl-1-tosylpyrrolidine-2-carboxamide
(7d)
20
White solid; yield: 592 mg (86%); mp 93–95 °C; [α]D –118.9 (c
0.37, MeOH).
IR (neat): 3335, 2974, 2950, 2881, 1675, 1597, 1450, 1391, 1342,
1197, 1158, 1096, 997 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.81–7.77 (m, 2 H), 7.31–7.29 (m,
2 H), 4.84–4.83 (m, 1 H), 3.78 (s, 3 H), 3.45–3.38 (m, 2 H), 3.19 (s,
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2014, 46, 320–330